Emma Clark
About
Emma Clark is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology.
According to data from OpenAlex, Emma Clark has authored 22 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 9 papers in Epidemiology and 8 papers in Molecular Biology. Recurrent topics in Emma Clark's work include Clostridium difficile and Clostridium perfringens research (15 papers), Microscopic Colitis (9 papers) and Gut microbiota and health (7 papers). Emma Clark is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (15 papers), Microscopic Colitis (9 papers) and Gut microbiota and health (7 papers). Emma Clark collaborates with scholars based in United Kingdom, United States and Ivory Coast. Emma Clark's co-authors include Mark H. Wilcox, Anthony M. Buckley, Inês B. Moura, Jane Freeman, C. H. Chilton, Hannah C. Harris, Georgina Davis, K. Morris, Jon J. Vernon and José Palacios and has published in prestigious journals such as The Journal of Infectious Diseases, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology.
In The Last Decade
Emma Clark
20 papers receiving 340 citations
Peers
Emma Clark
Eugénie Bassères United States
Sarah Larcombe Australia
Adrián Martínez-Meléndez Mexico
Carlos Quesada-Gómez Costa Rica
Piotr Obuch-Woszczatyński Poland
Brian Kullin South Africa
H. Boureau France
Justin L. Sonnenburg United States
Georgina Davis United Kingdom
Peter Kelley Australia
Citations per year, relative to Emma Clark Emma Clark (= 1×)
peers
Eugénie Bassères
Countries citing papers authored by Emma Clark
Since
Specialization
Citations
This map shows the geographic impact of Emma Clark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Clark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Clark more than expected).
Fields of papers citing papers by Emma Clark
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Emma Clark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Clark. The network helps show where Emma Clark may publish in the future.
Co-authorship network of co-authors of Emma Clark
This figure shows the co-authorship network connecting the top 25 collaborators of Emma Clark. A scholar is included among the top collaborators of Emma Clark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Clark. Emma Clark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Helliwell, Jack, C. H. Chilton, Caroline Young, et al.. (2025). Perioperative changes in the microbiome during rectal cancer surgery: exploratory analysis of the National Institute for Health and Care Research (NIHR) IntAct trial. British journal of surgery. 112(9).
2.
Clark, Emma, et al.. (2025). Development of a midwifery regulatory environment index using data from the Global Midwives’ Associations map survey. BMC Health Services Research. 25(1). 728–728.
3.
Freeman, Jane, Ingrid M. J. G. Sanders, Céline Harmanus, et al.. (2025). Antimicrobial susceptibility testing of Clostridioides difficile: a dual-site study of three different media and three therapeutic antimicrobials. Clinical Microbiology and Infection. 31(6). 1011–1017.
4.
Freeman, Jane, Virginie Viprey, Emma Clark, et al.. (2024). Antimicrobial susceptibility in Clostridioides difficile varies according to European region and isolate source. JAC-Antimicrobial Resistance. 6(4). dlae112–dlae112.
5.
Viprey, Virginie, Emma Clark, & Kerrie Davies. (2024). Diagnosis of Clostridioides difficile infection and impact of testing. Journal of Medical Microbiology. 73(12).
6.
Dingle, Kate E., Jane Freeman, Xavier Didelot, et al.. (2023). Penicillin Binding Protein Substitutions Cooccur with Fluoroquinolone Resistance in Epidemic Lineages of Multidrug-Resistant Clostridioides difficile. mBio. 14(2). e0024323–e0024323.
7.
Moura, Inês B., Ayman Grada, Emma Clark, et al.. (2022). Profiling the Effects of Systemic Antibiotics for Acne, Including the Narrow-Spectrum Antibiotic Sarecycline, on the Human Gut Microbiota. Frontiers in Microbiology. 13. 901911–901911.
8.
Barroso, Julie, et al.. (2022). Critical Care Nurses’ Experiences of Caring for Patients With COVID-19: Results of a Thematic Analysis. American Journal of Critical Care. 31(4). 275–282.
9.
Kristan, Mojca, Constant Edi, Emma Clark, et al.. (2021). Overabundance of Asaia and Serratia Bacteria Is Associated with Deltamethrin Insecticide Susceptibility in Anopheles coluzzii from Agboville, Côte d’Ivoire. Microbiology Spectrum. 9(2). e0015721–e0015721.
10.
Sidorov, Igor A., Sam Nooij, Céline Harmanus, et al.. (2021). Haem is crucial for medium-dependent metronidazole resistance in clinical isolates of Clostridioides difficile. Journal of Antimicrobial Chemotherapy. 76(7). 1731–1740.
11.
Harris, Hannah C., Anthony M. Buckley, Emma Clark, et al.. (2021). The effect of intestinal microbiota dysbiosis on growth and detection of carbapenemase-producing Enterobacterales within an in vitro gut model. Journal of Hospital Infection. 113. 1–9.
12.
Moura, Inês B., Jessica A. Bryant, Emma Clark, et al.. (2021). Biofilms harbour Clostridioides difficile, serving as a reservoir for recurrent infection. npj Biofilms and Microbiomes. 7(1). 16–16.
13.
Buckley, Anthony M., Inês B. Moura, Norie Arai, et al.. (2021). Trehalose-Induced Remodelling of the Human Microbiota Affects Clostridioides difficile Infection Outcome in an In Vitro Colonic Model: A Pilot Study. Frontiers in Cellular and Infection Microbiology. 11. 670935–670935.
14.
Buckley, Anthony M., Inês B. Moura, Emma Clark, et al.. (2021). The use of first-generation cephalosporin antibiotics, cefalexin and cefradine, is not associated with induction of simulated Clostridioides difficile infection. Journal of Antimicrobial Chemotherapy. 77(1). 148–154.
15.
Clark, Emma, Mojca Kristan, Constant Edi, et al.. (2020). Association of Reduced Long-Lasting Insecticidal Net Efficacy and Pyrethroid Insecticide Resistance With Overexpression of CYP6P4 , CYP6P3, and CYP6Z1 in Populations of Anopheles coluzzii From Southeast Côte d’Ivoire. The Journal of Infectious Diseases. 225(8). 1424–1434.
16.
Moura, Inês B., et al.. (2020). Method comparison for the direct enumeration of bacterial species using a chemostat model of the human colon. BMC Microbiology. 20(1). 2–2.
17.
Roberts, April K., Hannah C. Harris, Michael L. Smith, et al.. (2020). A Novel, Orally Delivered Antibody Therapy and Its Potential to Prevent Clostridioides difficile Infection in Pre-clinical Models. Frontiers in Microbiology. 11. 578903–578903.
18.
Rooney, Christopher, Anna E. Sheppard, Emma Clark, et al.. (2019). Dissemination of multiple carbapenem resistance genes in an in vitro gut model simulating the human colon. Journal of Antimicrobial Chemotherapy. 74(7). 1876–1883.
19.
Freeman, Jane, Jon J. Vernon, K. Morris, et al.. (2019). Five-year Pan-European, longitudinal surveillance of Clostridium difficile ribotype prevalence and antimicrobial resistance: the extended ClosER study. European Journal of Clinical Microbiology & Infectious Diseases. 39(1). 169–177.
20.
Moura, Inês B., et al.. (2018). Omadacycline Gut Microbiome Exposure Does Not Induce Clostridium difficile Proliferation or Toxin Production in a Model That Simulates the Proximal, Medial, and Distal Human Colon. Antimicrobial Agents and Chemotherapy. 63(2).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Eugénie Bassères Breakdown of academic impact, for papers by Sarah Larcombe Breakdown of academic impact, for papers by Adrián Martínez-Meléndez Breakdown of academic impact, for papers by Carlos Quesada-Gómez Breakdown of academic impact, for papers by Piotr Obuch-Woszczatyński Breakdown of academic impact, for papers by Brian Kullin Breakdown of academic impact, for papers by H. Boureau Breakdown of academic impact, for papers by Justin L. Sonnenburg Breakdown of academic impact, for papers by Georgina Davis Breakdown of academic impact, for papers by Peter Kelley